Cargando…
Efficacy and Safety of Empagliflozin in Type 2 Diabetes Mellitus Saudi Patients as Add-On to Antidiabetic Therapy: A Prospective, Open-Label, Observational Study
The Saudi Food and Drug Authority (SFDA) approved sodium-glucose cotransporter-2 (SGLT2) inhibitors in 2018. The efficacy and safety of empagliflozin (EMPA) have been confirmed in the U.S., Europe, and Japan for patients with type 2 diabetes mellitus (T2DM); however, analogous evidence is lacking fo...
Autores principales: | Althobaiti, Fahad M., Alsanosi, Safaa M., Falemban, Alaa H., Alzahrani, Abdullah R., Fataha, Salma A., Salih, Sara O., Alrumaih, Ali M., Alotaibi, Khalid N., Althobaiti, Hazim M., Al-Ghamdi, Saeed S., Ayoub, Nahla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410062/ https://www.ncbi.nlm.nih.gov/pubmed/36013008 http://dx.doi.org/10.3390/jcm11164769 |
Ejemplares similares
-
Case Reports Study on Methanol Poisoning in King Abdul Aziz Specialist Hospital, Taif, Saudi Arabia
por: Alqurashi, Ghadi I., et al.
Publicado: (2023) -
Medication Adherence among Patients with Chronic Diseases in Saudi Arabia
por: Alosaimi, Khulud, et al.
Publicado: (2022) -
Knowledge, attitude and practice among mothers on the relationship between honey and botulism in Saudi Arabian infants: a cross-section study
por: Bamumin, Asma, et al.
Publicado: (2023) -
Toxicity of Nab-Paclitaxel Compared to Paclitaxel in a Tertiary Hospital in Jeddah, Saudi Arabia: A Retrospective Cohort Study
por: Alhebshi, Suha A, et al.
Publicado: (2023) -
Knowledge, Attitude, and Practice of Bee Venom Acupuncture Therapy on Rheumatoid Arthritis Among Patients in Saudi Arabia
por: Sharaf, Shahd E, et al.
Publicado: (2022)